Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9


Liposomal Curcumin is Better than Curcumin to Alleviate Complications in Experimental Diabetic Mellitus.

Bulboacă AE, Porfire AS, Tefas LR, Boarescu PM, Bolboacă SD, Stănescu IC, Bulboacă AC, Dogaru G.

Molecules. 2019 Feb 27;24(5). pii: E846. doi: 10.3390/molecules24050846.


The effect of intravenous administration of liposomal curcumin in addition to sumatriptan treatment in an experimental migraine model in rats.

Bulboacă AE, Bolboacă SD, Stănescu IC, Sfrângeu CA, Porfire A, Tefas L, Bulboacă AC.

Int J Nanomedicine. 2018 May 25;13:3093-3103. doi: 10.2147/IJN.S162087. eCollection 2018.


Preemptive Analgesic and Antioxidative Effect of Curcumin for Experimental Migraine.

Bulboacă AE, Bolboacă SD, Stănescu IC, Sfrângeu CA, Bulboacă AC.

Biomed Res Int. 2017;2017:4754701. doi: 10.1155/2017/4754701. Epub 2017 Oct 24.


Association between low thyroid-stimulating hormone, posterior cortical atrophy and nitro-oxidative stress in elderly patients with cognitive dysfunction.

Bulboacă AE, Bolboacă SD, Bulboacă AC, Prodan CI.

Arch Med Sci. 2017 Aug;13(5):1160-1167. doi: 10.5114/aoms.2016.60129. Epub 2016 May 23.


Ethical considerations in providing an upper limb exoskeleton device for stroke patients.

Bulboacă AE, Bolboacă SD, Bulboacă AC.

Med Hypotheses. 2017 Apr;101:61-64. doi: 10.1016/j.mehy.2017.02.016. Epub 2017 Mar 2.


Combined rasagiline and antidepressant use in Parkinson disease in the ADAGIO study: effects on nonmotor symptoms and tolerability.

Smith KM, Eyal E, Weintraub D; ADAGIO Investigators.

JAMA Neurol. 2015 Jan;72(1):88-95. doi: 10.1001/jamaneurol.2014.2472.


Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage.

Filippi M, Rocca MA, Pagani E, De Stefano N, Jeffery D, Kappos L, Montalban X, Boyko AN, Comi G; ALLEGRO Study Group.

J Neurol Neurosurg Psychiatry. 2014 Aug;85(8):851-8. doi: 10.1136/jnnp-2013-306132. Epub 2013 Sep 12.


Placebo-controlled trial of oral laquinimod for multiple sclerosis.

Comi G, Jeffery D, Kappos L, Montalban X, Boyko A, Rocca MA, Filippi M; ALLEGRO Study Group.

N Engl J Med. 2012 Mar 15;366(11):1000-9. doi: 10.1056/NEJMoa1104318.


A double-blind, delayed-start trial of rasagiline in Parkinson's disease.

Olanow CW, Rascol O, Hauser R, Feigin PD, Jankovic J, Lang A, Langston W, Melamed E, Poewe W, Stocchi F, Tolosa E; ADAGIO Study Investigators.

N Engl J Med. 2009 Sep 24;361(13):1268-78. doi: 10.1056/NEJMoa0809335. Erratum in: N Engl J Med. 2011 May 12;364(19):1882.

Supplemental Content

Loading ...
Support Center